Warren NelsonWarren Nelson
|
 |
Soma (Carisoprodol). Carisoprodol ( Soma ) induced myoclonic encephalopathy.CASE REPORT. Agitation, hypertonia, and a myoclonicencephalopathy may be seen with significant Carisoprodol ( Soma ) intoxication. Reported drivingbehaviors included erratic siffre travel, weaving, driving slowly, swerving,stopping in traffic, and hitting parked cars and other stationary objects.Drivers on contact by the police online pharmacy displayed poor balance and coordination,horizontal gaze nystagmus, bloodshot eyes, unsteadiness, slurred articulated, slowresponses, tendency to doze off or fall strung out, difficulty standing, walking orexiting their vehicles, and disorientation. online pharmacy prescription It acts by blocking electrical communication among nerves in the reticular formation of the brain and in the spinal kaleb. A review of cases presenting to the San Coop Division ofthe California Poison Control System online pharmacy during 1997 suggests that Carisoprodol ( Soma ) ismore commonly associated with agitation and bizarre movement disorders than thecurrent literature suggests. In 21cases, however, no other drugs were detected, and similar symptoms were present.Impairment appeared to be possible at any concentration of these online medicines two drugs;however, the most severe driving impairment and most overt symptoms ofintoxication were noted when the combined concentration exceeded 10 mg/L, alevel still within the normal therapeutic range.. Soma (carisoprodol) is used together with rest and physical therapy for short-term relief of painful muscle conditions. Carisoprodol ( Soma )overdose is thought to induce simple central nervous system depression. The blood Carisoprodol ( Soma ) was 71micrograms/mL; the meprobamate was 26 micrograms/mL. Thiscase demonstrates a severe overdose with symptoms more consistent with myoclonicencephalopathy. He developedagitation, tachycardia, myoclonus, and coma. Many of these cases had alcohol orother centrally acting drugs present also, making difficult the attribution ofthe documented impairment specifically to Carisoprodol ( Soma ) and meprobamate. Carisoprodol ( Soma ), meprobamate, and driving impairment.This paper considers the pharmacology of the centrally acting muscle relaxantCarisoprodol ( Soma ), and its metabolite meprobamate, which is also administered as ananxiolytic in its own right. A 39-year-old man ingested 35 g Carisoprodol ( Soma ). Symptomatology and driving impairment wereconsistent with other CNS depressants, most notably alcohol. Carisoprodol is a muscle relaxant. A series of 104 incidents in which these drugs weredetected in the blood of drivers involved in accidents or arrested for impaireddriving was considered, with respect to the analytical toxicology results,patterns of drug use in these subjects, the driving behaviors exhibited, and thesymptoms observed in the drivers. The pharmacology and potential mechanisms oftoxicity are discussed. Literature implicating these drugs in impaireddriving is also reviewed.
|